Premier Biomedical, Inc. (BIEI) Announces Breakthrough in Cancer Research
Premier Biomedical has announced successful advances in cancer-focused research. The company’s researchers have successfully killed a cancer tumor in a test tube by simply removing crucial molecular compounds that are necessary for the cancer’s development. They accomplished this by utilizing the Felder Doctrine, which states: “Physically remove the pathophysiologic basis of the disease.” Currently used methods for treating cancer, like chemotherapy and many conventional cancer-fighting drugs, are able to target only one single antigen, which permits another antigen to survive the treatment and allows the cancer to progress. Additionally, these blockers or inhibitors are frequently accompanied by dangerous side effects…